Literature DB >> 6361152

Cascade immunization: a method of obtaining polyspecific antisera against crude fractions of antigens.

J Thalhamer, J Freund.   

Abstract

Between 20 and 30 precipitation lines are usually obtained by crossed immune electrophoresis of an Escherichia coli cytoplasmic extract against antisera produced against that extract in individual rabbits. With a combination of several such antisera, the number of precipitation lines increases to 30-40. Nevertheless, extracts as used in this work contain many antigens in addition to those thus detected. Intermolecular immune competition may be avoided by removing strong immunogens from the extracts. The remaining antigens which give no immune response in the primary immunization are used for further immunization. New antibody production against 8-14 additional antigens occurs after one such 'cascade immunization' step. Separation of strong from weak immunogens is performed by preparative CIE and the use of immuno-affinity columns. The procedure is called cascade immunization because it involves repeated removal of antigens and production of further antisera directed against antigens in the remainder.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6361152     DOI: 10.1016/0022-1759(84)90335-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Alteration of proliferation and subtle changes of protein synthesis in autologous transplanted spleens.

Authors:  J Thalhamer; C Lenglachner; W Grillenberger; W Pimpl
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

2.  Immunization procedures for E. coli proteins.

Authors:  V R Anicetti; M A Simonetti; L L Blackwood; A J Jones; A B Chen
Journal:  Appl Biochem Biotechnol       Date:  1989-11       Impact factor: 2.926

3.  Evaluation of enzyme immunoassays in the diagnosis of camel (Camelus dromedarius) trypanosomiasis: a preliminary investigation.

Authors:  P F Rae; M V Thrusfield; A Higgins; C G Aitken; T W Jones; A G Luckins
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.